NeoGenomics (NEO) Earnings Date, Estimates & Call Transcripts $16.92 +0.09 (+0.53%) (As of 05:46 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NeoGenomics Latest Earnings SummaryActual EPS (Nov. 5) $0.05 Beat By $0.04 Consensus EPS (Nov. 5) $0.01 NeoGenomics announced Q3 2024 earnings on November 5, 2024, reporting an EPS of $0.05, which beat the consensus estimate of $0.01 by $0.04. Quarterly revenue rose 10.5% year-over-year to $167.80 million, above analysts' expectations of $167 million. With a trailing EPS of -$0.61, NeoGenomics' earnings are expected to grow next year, from ($0.16) to ($0.06) per share. Conference CallConference Call TranscriptEarnings Slide DeckSEC 10-Q/10-K FilingPowered by Get NeoGenomics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeoGenomics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNEO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NEO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NeoGenomics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242-$0.13-$0.08-$0.11 Q2 20242-$0.11-$0.04-$0.08 Q3 20242-$0.08-$0.04-$0.06 Q4 20243-$0.07-$0.05-$0.06 FY 20249-$0.39-$0.21-$0.30 Q1 20252-$0.07-$0.03-$0.05 Q2 20252-$0.06-$0.02-$0.04 Q3 20252-$0.05-$0.01-$0.03 Q4 20251-$0.01-$0.01-$0.01 FY 20257($0.19)($0.07) ($0.13) NeoGenomics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/5/2024Q3 2024$0.01$0.05+$0.04$0.10$167.00M$167.80M7/29/2024Q2 2024-$0.0020$0.03+$0.0320$0.07$161.82M$164.50M4/30/2024Q1 2024-$0.07-$0.08 -$0.01$0.05$149.82M$156.24M2/20/2024Q4 2023-$0.07-$0.02+$0.05$0.07$152.90M$155.55M11/6/2023Q3 2023-$0.11-$0.06+$0.05$0.03$142.15M$151.95M8/8/2023Q2 2023-$0.15-$0.09+$0.06$0.01$138.22M$146.92M Get the Latest News and Ratings for NEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeoGenomics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023Q1 2023-$0.16-$0.13+$0.03-$0.01$126.31M$137.22M2/23/2023Q4 2022-$0.19-$0.10+$0.09-$0.02$129.96M$138.71M NeoGenomics Earnings - Frequently Asked Questions When did NeoGenomics announce their last quarterly earnings? NeoGenomics (NASDAQ:NEO) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on NEO's earnings history. What guidance has NeoGenomics issued on next quarter's earnings? NeoGenomics issued an update on its FY 2024 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of 0.080-0.100 for the period, compared to the consensus EPS estimate of 0.060. The company issued revenue guidance of $655.0 million-$667.0 million, compared to the consensus revenue estimate of $661.7 million. Did NeoGenomics beat their earnings estimates last quarter? In the previous quarter, NeoGenomics (NASDAQ:NEO) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.04. Learn more on analysts' earnings estimate vs. NEO's actual earnings. How can I listen to NeoGenomics's earnings conference call? The conference call for NeoGenomics's latest earnings report can be listened to online. Listen to Conference Call How can I read NeoGenomics's conference call transcript? The conference call transcript for NeoGenomics's latest earnings report can be read online. Read Transcript How can I view NeoGenomics's earnings report? NeoGenomics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded annual revenue of $644.12 million. How much profit does NeoGenomics generate each year? NeoGenomics (NASDAQ:NEO) has a recorded net income of -$87.97 million. NEO has generated -$0.61 earnings per share over the last four quarters. What is NeoGenomics's EPS forecast for next year? NeoGenomics's earnings are expected to grow from ($0.16) per share to ($0.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies HealthEquity Earnings Date Bilibili Earnings Date QXO Earnings Date Etsy Earnings Date MARA Earnings Date Lyft Earnings Date TriNet Group Earnings Date CarGurus Earnings Date Alight Earnings Date ACV Auctions Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles S&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol This page (NASDAQ:NEO) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredIs Jeff Bezos Crowning the Next Nvidia?It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
